Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in India Read more
Zydus announces non-exclusive patent licensing agreement with Takeda for ‘Vault’ (Vonoprazan) in India Read more
Takeda’s phase 2b study of Mezagitamab shows potential to transform treatment of primary immune Thrombocytopenia Read more
Sun Pharma signs non-exclusive patent licensing agreement with Takeda for introducing Novel Gastrointestinal Drug, Voltapraz (Vonoprazan) in India Read more
We have attempted to make the dengue vaccine more affordable than other innovative vaccines Read more
Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies: GlobalData Read more